CD274 and Cachexia: The PD‐(L)1 inhibitors were discontinued due to AEs in 3 patients (14.3%) with refractory cachexia, 3 patients (3.5%) with cachexia and 14 patients (4.7%) with pre‐cachexia (p = 0.114).